Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Novartis India stock

500672.BO
INE234A01025

Price

818.60
Today +/-
+0.16
Today %
+1.74 %

Novartis India stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Novartis India stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Novartis India stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Novartis India stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Novartis India's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Novartis India Stock Price History

DateNovartis India Price
2/19/2025818.60 undefined
2/18/2025804.45 undefined
2/17/2025798.65 undefined
2/14/2025804.95 undefined
2/13/2025823.45 undefined
2/12/2025850.00 undefined
2/11/2025844.80 undefined
2/10/2025850.35 undefined
2/7/2025869.40 undefined
2/6/2025875.00 undefined
2/5/2025850.00 undefined
2/4/2025852.55 undefined
2/3/2025850.40 undefined
2/1/2025852.65 undefined
1/31/2025868.25 undefined
1/30/2025855.45 undefined
1/29/2025886.10 undefined
1/28/2025892.05 undefined
1/27/2025900.25 undefined
1/24/2025909.20 undefined
1/23/2025901.00 undefined
1/22/2025869.50 undefined

Novartis India Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Novartis India, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Novartis India from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Novartis India’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Novartis India. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Novartis India’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Novartis India’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Novartis India’s growth potential.

Novartis India Revenue, EBIT and net profit per share

DateNovartis India RevenueNovartis India EBITNovartis India Net Income
20243.35 B undefined629.2 M undefined851.9 M undefined
20233.79 B undefined600.8 M undefined1.03 B undefined
20224 B undefined176 M undefined-37.2 M undefined
20213.81 B undefined147.7 M undefined209 M undefined
20204.38 B undefined8.4 M undefined100.8 M undefined
20194.91 B undefined126.5 M undefined517.7 M undefined
20185.64 B undefined-56.5 M undefined783.6 M undefined
20176.56 B undefined276.4 M undefined572.2 M undefined
20166.9 B undefined358.9 M undefined1.98 B undefined
20158.73 B undefined-19.2 M undefined791.1 M undefined
20148.62 B undefined-161.9 M undefined985.3 M undefined
20139.03 B undefined873.2 M undefined1.2 B undefined
20128.44 B undefined1.44 B undefined1.52 B undefined
20117.51 B undefined1.52 B undefined1.47 B undefined
20106.24 B undefined1.02 B undefined1.16 B undefined
20095.99 B undefined1.09 B undefined1.04 B undefined
20085.53 B undefined959.8 M undefined972.3 M undefined
20075.42 B undefined858.9 M undefined885.5 M undefined
20065.26 B undefined809.6 M undefined1.08 B undefined
20054.71 B undefined644.6 M undefined651.2 M undefined

Novartis India Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
6.637.478.244.384.614.725.054.715.265.425.535.996.247.518.449.038.628.736.96.565.644.914.383.8143.793.35
-12.7010.33-46.835.202.307.04-6.6311.563.102.078.314.1220.3712.387.00-4.551.29-21.00-4.88-14.08-12.98-10.68-12.984.85-5.28-11.54
47.1447.3047.5446.6350.0847.4248.1552.0650.8555.0056.5158.6859.8363.6263.1158.8653.1958.3957.7252.5355.7158.8157.6960.7754.6345.9739.58
3.133.533.922.042.312.242.432.452.672.983.133.523.734.785.335.324.595.13.983.453.142.892.532.322.181.741.33
0.380.751.030.420.650.621.140.651.080.890.971.041.161.471.521.20.990.791.980.570.780.520.10.21-0.041.030.85
-94.7838.61-59.5756.22-5.0583.39-42.7465.59-17.909.836.6911.7626.493.68-21.25-17.71-19.70150.57-71.1436.89-33.97-80.66109.00-117.70-2,891.89-17.62
---------------------------
---------------------------
31.931.931.9323232323232323232323232323232323027.624.724.724.724.724.6924.69
---------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Novartis India Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Novartis India is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (B)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (B)LONG-T. REC. (B)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                     
0.10.110.280.690.180.450.090.651.260.050.150.540.570.870.820.380.168.411.248.147.746.115.84.975.165.545.85
1.231.141.320.50.60.480.690.420.40.420.390.460.460.630.70.820.780.510.50.410.440.460.380.390.450.570.64
0.770.730.890.470.440.630.921.572.223.454.160.560.580.220.170.220.240.280.090.240.270.330.510.460.130.030
1.241.431.40.540.550.720.510.660.610.670.680.50.510.540.791.11.040.660.720.880.580.620.610.50.580.560.46
000000000004.185.085.726.857.818.410.80.080.060.50.540.820.920.760.080.04
3.333.413.892.21.782.272.23.294.494.65.386.237.217.989.3310.3410.6110.6412.649.739.528.068.127.237.086.776.99
0.810.970.931.181.131.020.250.220.10.10.090.090.080.080.10.10.080.080.070.060.050.150.760.640.240.190.07
0.380.380.710.340.370.371.060.480.070.040.220.230.1600.020000000.010.010.010.010.010
00000000000000.690.710.811.151.441.41.461.261.350.320.330.350.840.7
00101010101000002111000000000000
000000000000000000000000000
0000.110.140.140.180.110.110.130.130.140.160.180.170.160.180.230.220.240.270.271.561.821.912.011.48
1.191.351.651.631.641.531.50.80.280.270.440.460.40.951.011.081.411.751.691.771.591.772.662.792.53.062.26
4.524.765.543.833.423.83.714.094.774.875.826.697.618.9310.3411.4112.0212.3914.3311.511.119.8310.7810.029.589.839.25
                                                     
319319319160160160160160160160160160160160160160160160160141123123123123123123.4123.4
000229229229229229229229229229229229229229229022900000000
2.012.452.961.281.72.052.172.462.993.54.14.765.556.647.798.619.2310.1711.629.137.287.517.127.026.827.637.32
000000000000000000-69-74-62-43-33-30-22-0.40
000000000000000000000000000
2.332.773.281.672.092.442.562.843.383.894.495.155.947.038.1899.6110.3311.949.27.347.597.217.116.927.767.45
1.070.961.080.520.40.430.440.520.490.520.540.60.650.790.981.21.080.650.70.731.060.910.730.550.720.60.62
2282061941921691661331098449201513188184214246223315311221227177255259305.1483.5
0.60.550.810.310.440.50.510.530.760.330.770.921.010.720.770.710.80.91.030.822.020.711.310.661.130.650.45
22037900010000000000000000000.2
00000000000002121000001181275741.218.8
1.921.712.121.021.021.11.091.161.330.891.341.541.671.71.932.122.121.772.051.863.311.852.331.592.161.591.57
2722751499491068761696392433010000000565498183173.950.7
0001882101830220000000000000000000
0000000000000199226288286287345444462382677824312304178.4
0.270.280.151.140.320.270.060.090.060.090000.20.230.290.290.290.350.440.460.381.241.320.50.480.23
2.21.992.272.161.331.371.151.251.390.991.341.551.671.92.162.412.412.062.392.33.772.233.572.912.662.071.8
4.524.765.543.833.423.83.714.094.774.875.826.697.618.9310.3411.4112.0212.3914.3311.511.19.8210.7810.029.589.839.25
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Novartis India provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Novartis India's financial health and stability.

Assets

Novartis India's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Novartis India must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Novartis India after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Novartis India's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)

Novartis India stock margins

The Novartis India margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Novartis India. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Novartis India.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Novartis India's sales revenue. A higher gross margin percentage indicates that the Novartis India retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Novartis India's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Novartis India's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Novartis India's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Novartis India. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Novartis India's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Novartis India Margin History

Novartis India Gross marginNovartis India Profit marginNovartis India EBIT marginNovartis India Profit margin
202439.6 %18.78 %25.42 %
202345.97 %15.86 %27.29 %
202254.62 %4.4 %-0.93 %
202160.76 %3.87 %5.48 %
202057.7 %0.19 %2.3 %
201958.81 %2.58 %10.55 %
201855.71 %-1 %13.9 %
201752.54 %4.21 %8.72 %
201657.73 %5.2 %28.74 %
201558.39 %-0.22 %9.06 %
201453.19 %-1.88 %11.43 %
201358.86 %9.67 %13.25 %
201263.11 %17.01 %18.01 %
201163.62 %20.23 %19.52 %
201059.83 %16.38 %18.59 %
200958.67 %18.14 %17.3 %
200856.51 %17.34 %17.57 %
200755 %15.84 %16.33 %
200650.85 %15.39 %20.51 %
200552.06 %13.67 %13.81 %

Novartis India Stock Sales Revenue, EBIT, Earnings per Share

The Novartis India earnings per share therefore indicates how much revenue Novartis India has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Novartis India earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Novartis India's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Novartis India’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Novartis India's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Novartis India Revenue, EBIT and net profit per share

DateNovartis India Sales per ShareNovartis India EBIT per shareNovartis India Earnings per Share
2024135.71 undefined25.48 undefined34.5 undefined
2023153.39 undefined24.33 undefined41.86 undefined
2022161.89 undefined7.13 undefined-1.51 undefined
2021154.39 undefined5.98 undefined8.46 undefined
2020177.43 undefined0.34 undefined4.08 undefined
2019198.66 undefined5.12 undefined20.96 undefined
2018204.31 undefined-2.05 undefined28.39 undefined
2017218.74 undefined9.21 undefined19.07 undefined
2016215.59 undefined11.22 undefined61.97 undefined
2015272.93 undefined-0.6 undefined24.72 undefined
2014269.45 undefined-5.06 undefined30.79 undefined
2013282.3 undefined27.29 undefined37.42 undefined
2012263.84 undefined44.88 undefined47.51 undefined
2011234.75 undefined47.48 undefined45.83 undefined
2010195.03 undefined31.95 undefined36.25 undefined
2009187.34 undefined33.98 undefined32.41 undefined
2008172.95 undefined29.99 undefined30.38 undefined
2007169.45 undefined26.84 undefined27.67 undefined
2006164.35 undefined25.3 undefined33.72 undefined
2005147.34 undefined20.14 undefined20.35 undefined

Novartis India business model

Novartis India is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Novartis India Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Novartis India historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Novartis India shares outstanding

The number of shares was Novartis India in 2024 — This indicates how many shares 24.691 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Novartis India earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Novartis India's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Novartis India’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Novartis India's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Novartis India stock splits

In Novartis India's history, there have been no stock splits.

Novartis India dividend history and estimates

In 2024, Novartis India paid a dividend amounting to 25 INR. Dividend means that Novartis India distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Novartis India provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Novartis India’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Novartis India's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Novartis India Dividend History

DateNovartis India Dividend
202425 undefined
202337.5 undefined
202210 undefined
202110 undefined

Novartis India dividend payout ratio

In 2024, Novartis India had a payout ratio of 118.2%. The payout ratio indicates the percentage of the company's profits that Novartis India distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Novartis India represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Novartis India could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Novartis India's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Novartis India Payout Ratio History

DateNovartis India Payout ratio
2024118.2 %
2023118.2 %
2022-662.25 %
2021118.2 %
2020118.2 %
2019118.2 %
2018118.2 %
2017118.2 %
2016118.2 %
2015118.2 %
2014118.2 %
2013118.2 %
2012118.2 %
2011118.2 %
2010118.2 %
2009118.2 %
2008118.2 %
2007118.2 %
2006118.2 %
2005118.2 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Novartis India.

Novartis India shareholders

%
Name
Stocks
Change
Date
70.67914 % Novartis AG17,450,68006/30/2024
1.51732 % Lalbhai Group374,62706/30/2024
0.12854 % Dimensional Fund Advisors, L.P.31,73709/30/2024
0.03212 % Dimensional Fund Advisors, Ltd.7,93009/30/2024
0.00043 % Motilal Oswal Asset Management Company Ltd.107159/30/2024
1

Novartis India Executives and Management Board

Mr. Sanjay Murdeshwar

Novartis India Vice Chairman of the Board, Managing Director (since 2019)
Compensation 7.2 M

Mr. Jai Hiremath

(75)
Novartis India Non-Executive Independent Director
Compensation 1 M

Ms. Sandra Martryes

(69)
Novartis India Non-Executive Independent Director
Compensation 1 M

Mr. Sanker Parameswaran

(62)
Novartis India Non-Executive Independent Director
Compensation 1 M

Mr. Christopher Snook

(70)
Novartis India Non-Executive Non-Independent Chairman of the Board
1
2

Most common questions regarding Novartis India

What is the P/E ratio of Novartis India 2025?

The P/E ratio cannot be calculated for Novartis India at the moment.

What is the P/S ratio of Novartis India 2025?

The P/S cannot be calculated for Novartis India currently.

What is the Quality Investing of Novartis India?

The Quality Investing for Novartis India is 3/10.

What is the revenue of Novartis India 2025?

The revenue cannot currently be calculated for Novartis India.

How high is the profit of Novartis India 2025?

The profit cannot currently be calculated for Novartis India.

What is the business model of Novartis India

No history available for Novartis India.

What is the Novartis India dividend?

Novartis India pays a dividend of 10 INR distributed over payouts per year.

How often does Novartis India pay dividends?

The dividend cannot currently be calculated for Novartis India or the company does not pay out a dividend.

What is the Novartis India ISIN?

The ISIN of Novartis India is INE234A01025.

What is the Novartis India ticker?

The ticker of Novartis India is 500672.BO.

How much dividend does Novartis India pay?

Over the past 12 months, Novartis India paid a dividend of 25 INR . This corresponds to a dividend yield of about 3.05 %. For the coming 12 months, Novartis India is expected to pay a dividend of 25 INR.

What is the dividend yield of Novartis India?

The current dividend yield of Novartis India is 3.05 %.

When does Novartis India pay dividends?

Novartis India pays a quarterly dividend. This is distributed in the months of September, August, August, August.

How secure is the dividend of Novartis India?

Novartis India paid dividends every year for the past 4 years.

What is the dividend of Novartis India?

For the upcoming 12 months, dividends amounting to 25 INR are expected. This corresponds to a dividend yield of 3.05 %.

In which sector is Novartis India located?

Novartis India is assigned to the 'Health' sector.

Wann musste ich die Aktien von Novartis India kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Novartis India from 8/5/2024 amounting to 25 INR, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.

When did Novartis India pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Novartis India in the year 2024?

In the year 2024, Novartis India distributed 37.5 INR as dividends.

In which currency does Novartis India pay out the dividend?

The dividends of Novartis India are distributed in INR.

All fundamentals about Novartis India

Our stock analysis for Novartis India Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis India Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.